Kelyniam Global Releases Q1 Financials



Announces Shareholder Meeting

CANTON, Conn., May 13, 2024  /PRNewswire/ — Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its quarter ended March 31, 2024. 

Financial highlights for the three months ended March 31, 2024 and the same period in 2023 include: 

Total revenue of $957,447 compared to $596,455, an increase of 60.5%
Gross Margin of $743,719 compared to $467,773 an increase of 59.0%
Operating profit of $123,599 compared to a loss of $67,978 representing an increase to profitability of $191,577

Profitability was strongly enhanced by a year’s long effort in reconfiguring the Company’s structural costs and a tight focus on this year’s operations.  The Company saw those efforts pay off with decreased consulting …

Full story available on


Leave a Reply

Your email address will not be published. Required fields are marked *